Elevance Health is the latest health insurance company to report higher-than-expected medical costs as third quarter profits ...
We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating ...
In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Elevance Health (ELV – Research Report), with a ...
Elevance Health cut its annual profit expectation on Thursday due to increased medical costs in its government-backed plans, ...
Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its ...
The company’s earnings missed expectations, the latest sign of how medical expenses are squeezing insurers’ government ...
Shares of Elevance Health Inc. ELV plunged 10.59% to $444.35 Thursday, on what proved to be an all-around mixed trading ...
Elevance Health is "considering all of our options” to dispute the latest round of Medicare Advantage star ratings, President ...
CEO Gail Boudreaux says cut points are a large factor driving the decline of plans rated four stars or higher.
Elevance Health Inc. is seeking to sell investment-grade bonds as the big US insurer’s shares have fallen the most since 2020 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback